Leigh Baldwin & Co., LLC Merck & Co., Inc. Transaction History
Leigh Baldwin & Co., LLC
- $115 Billion
- Q4 2024
A detailed history of Leigh Baldwin & Co., LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Leigh Baldwin & Co., LLC holds 2,073,597 shares of MRK stock, worth $172 Million. This represents 1.8% of its overall portfolio holdings.
Number of Shares
2,073,597Holding current value
$172 Million% of portfolio
1.8%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,946Shares Held
1.93BCall Options Held
15.9MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA251MShares$20.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$6.7 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.08 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $210B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...